Hung-Chien Wei

Title: Innovations of Hung-Chien Wei in Cancer Treatment

Introduction

Hung-Chien Wei is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on combining protein vaccines with mesenchymal stem cells to inhibit tumor growth and metastasis in mammals.

Latest Patents

Hung-Chien Wei holds a patent for a method that involves administering an effective amount of stem cells containing a transgene encoding at least one oncogenic protein. This method is designed to inhibit the growth and/or metastasis of tumors in mammals. The stem cells used in this method are immortal and do not exhibit signs of neoplastic transformation. Additionally, the method includes administering a vaccine composition that contains at least one immunogenic protein capable of eliciting antibodies specific to the oncogenic protein. This innovative approach aims to provide a therapeutic kit for effectively treating cancer in mammals.

Career Highlights

Throughout his career, Hung-Chien Wei has worked with various companies, including Healthbanks Biotech Co., Ltd. and Kooper Biotech Co., Ltd. His experience in these organizations has contributed to his expertise in biotechnology and cancer research.

Collaborations

Hung-Chien Wei has collaborated with notable professionals in his field, including Win-Ping Deng and Hsiu-Kang Chang. These collaborations have further enhanced his research and development efforts in cancer treatment.

Conclusion

Hung-Chien Wei's innovative work in combining protein vaccines with mesenchymal stem cells represents a significant advancement in cancer treatment. His patented methods and collaborations highlight his commitment to improving therapeutic options for patients.